March 5 (Reuters) - MiniMed, the diabetes business of medical device maker Medtronic MDT.N, said on Thursday it has raised $560 million in its U.S. initial public offering.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.